Business News • PR NewsWire • New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

KING OF PRUSSIA, Pa., March 19, 2011 /PRNewswire/ -- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with

View More : http://www.prnewswire.com/news-releases/new-model-provides-insights-into-intravenous-and-subcutaneous-immunoglobulin-pha...

Releted News by prnewswire

NIA Addresses Latest BLS CPI Inflation Data

British Expatriate Gives a First-Hand Account of Events in Manama, Repudiates BBC's Coverage of Protests in Bahrain

Corn Ethanol: Who Pays? Who Benefits? -Ken G. Glozer